Popular candidates from both sides of the aisle haven't always sided with their party on how best to fix Social Security.
This profitable pot stock's quarterly dividend has grown 140% in just one year.
The fast-growing green rush has a number of important questions that we want answered.
Medical marijuana drug developers are often smothered in hype and rarely deliver any reward.
These cannabis growers are doing things a bit differently.
A Wall Street investment bank lowered its price target on this popular pot stock by more than 10%.
Marijuana may not have investors seeing much green through 2020.
This three-year deal covers the extraction, formulation, and packaging of 230,000 kilos of cannabis and hemp biomass.
There's one big reason pessimism has been building for a number of popular marijuana stocks.
These pot stocks have a lower forward price-to-earnings ratio than the broad-based S&P 500.
This more than $800 million acquisition is now under the Justice Department's microscope.
The green rush could have you seeing red if you succumb to one or more of these cannabis-investing mistakes.
Hint: It had nothing to do with the company's headline numbers.
Millennials love cannabis stocks. Unfortunately, two of their favorites could be duds.
This newly-public multistate dispensary operator has introduced its own marijuana credit card for consumers.
Increasing payroll taxes on the wealthy isn't as cut-and-dried as you'd think.
Marijuana-stock income statements feature a lot of one-time costs, benefits, and adjustments. Here's what happens when you remove them and focus on the numbers that matter.
Nearly 80% of legal worldwide marijuana sales will come from the United States in 2019.
Chances are good that you'll be leaning on Social Security, in some capacity, to make ends meet during retirement.
This U.S. multistate cannabis operator just landed a game-changing cannabidiol distribution deal.